細胞培養市場：製品、用途、最終用途別-2024-2030年の世界予測

細胞培養市場規模は2023年に262億9,000万米ドルと推定され、2024年には301億2,000万米ドルに達し、CAGR 14.58％で2030年には682億米ドルに達すると予測されています。

細胞培養は、生体のような自然環境とは異なる制御された環境で細胞を増殖させるために使用される実験手法です。この方法により、研究者や科学者は細胞の挙動、生物学、生理学を詳細に研究することができます。細胞培養は、医療研究、製薬、バイオテクノロジー、さらには製造業の一部など、様々なセグメントで活用されています。細胞培養技術の応用範囲は、医薬品開発、ワクチン製造、がん研究、遺伝子工学、生物製剤の製造など、多岐にわたります。新薬の開発、毒性試験、疾病メカニズムの解明において重要な役割を果たしています。製薬業界やバイオテクノロジー業界では、細胞培養はバイオ医薬品や抗体の製造において極めて重要な役割を担っています。さらに、再生医療や組織工学における細胞培養の役割は、慢性疾患や病態に対する治療戦略の開発における重要性を強調しています。細胞培養市場の成長には、3D細胞培養や自動細胞培養システムなどの細胞培養技術の革新、治療用モノクローナル抗体の需要の増加、バイオテクノロジーや製薬研究活動への投資の増加、世界の慢性疾患の罹患率の上昇など、いくつかの要因がプラスに働いています。しかし、細胞培養市場は、高度な細胞培養技術に伴う高コスト、倫理的問題、培養維持の複雑さ、汚染のリスクなど、ある種の制約に直面しています。一方、3D細胞培養技術の進歩、個人の遺伝子プロファイルに合わせた治療を行う個別化医療における細胞培養の使用、再生医療における細胞培養の応用研究、持続可能な食品生産のための細胞培養を使用した培養肉の急成長セグメントは、細胞培養市場の発展に新たな道を開きます。

製品：細胞培養では、信頼性、拡大性、高度な機能を備えた機器への選好が高まる

消耗品は定期的に使用され、交換が必要な製品です。細胞培養の作業の品質と完全性を確保する上で重要な役割を果たします。バイオリアクター付属品とは、生物学的に活性な環境をサポートする装置であるバイオリアクターで使用され、その効率と生産量を向上させるためのコンポーネントです。培地は、細胞が増殖するための栄養豊富な溶液であり、古典的な培地と塩類と無血清培地に分けられます。試薬とは、望ましい効果をもたらすために細胞培養に添加される物質や化合物であり、例えば、細菌／真菌汚染を防ぐために使用される抗生物質／抗真菌剤、細胞が培養容器に接着するのを助けるための接着因子／マトリックス因子、浸透圧バランスとpHを維持するためのバランス塩溶液などがあります。細胞工場システム／細胞スタック、フラスコ、マルチウェルプレートは、細胞を培養する容器です。様々なサイズと形態があり、様々なタイプの細胞培養のニーズに合わせて調整されます。従来のバイオリアクターやシングルユース・バイオリアクターは、研究や生産目的で細胞を大量に培養するために不可欠です。特にシングルユース・バイオリアクターは、その利便性とコンタミネーションリスクの低減で注目されています。凍結保存システム、冷蔵庫、冷凍庫は、細胞や生物試料を適切な温度で保存し、長期間生存できるようにするために不可欠です。オートクレーブ、バイオセーフティキャビネット、二酸化炭素インキュベーターは、無菌環境を維持し、細胞培養の安全性と完全性を確保するために不可欠です。消耗品は継続的な出費であり、長期的には細胞培養の運用コスト全体に大きな影響を与えます。一方、機器は初期投資額は高くなりますが、耐用年数が長いため、長期的にコストを削減できる可能性があります。消耗品の選択は、多くの場合、品質、バッチの一貫性、倫理的配慮に重点を置くが、装置の好みは、信頼性、拡大性、培養条件やモニタリングを強化する高度な機能に傾く。

最終用途：病院や診断試験室における細胞培養の利用拡大による効率化と診断精度向上

病院や診断試験室では、細胞培養は主にがん診断、ウイルス試験、薬剤スクリーニングなどの診断目的で使用されています。正確性、信頼性、スピードが重視され、ワークフローを合理化し、人的ミスを減らすために自動化された細胞培養システムへの関心が高まっています。製薬・バイオテクノロジー企業は、医薬品開発、生物製剤製造、ワクチン製造における細胞培養のアプリケーションを考慮し、拡大性、一貫性、規制遵守を優先しています。新治療の市場投入までの時間を短縮できる、高収率で費用対効果の高い培養システムに重点が置かれています。研究機関や学術機関では、幹細胞研究、がん研究、再生医療など幅広い研究セグメントをサポートするため、柔軟性、多様性、特異性に富んだ細胞培養製品が注目されています。ここでの需要は、特殊な培地製剤、3D培養のような高度な培養システム、最先端の研究活動のサポートです。この3つのセグメントを比較すると、それぞれが最終的な目標によって形成された独自の要求を持っていることがわかる。病院や診断ラボは効率と診断精度を優先し、製薬会社やバイオテクノロジー会社は治療製造のための拡大性とコンプライアンスを重視し、研究機関や学術機関は幅広い研究用途に対応できる汎用性を求めています。

地域別洞察

バイオテクノロジー研究開発の中心地である米国は、細胞培養製品の重要な市場として際立っています。この地域の需要は、強固な研究インフラ、ライフサイエンスへの多額の投資、大手製薬会社やバイオテクノロジー会社の存在によって牽引されています。個別化医療と再生療法への注目は、市場をさらに押し上げます。南米細胞培養市場は、官民両部門による研究開発投資の増加によって成長段階にあります。アジア太平洋は、バイオ医薬品セクターの拡大、ライフサイエンスへの投資の増加、バイオテクノロジー新興企業に対する政府の支援により、細胞培養の需要が急増しています。中国市場は、再生医療、生物製剤製造、幹細胞研究の推進を目的とした政府のイニシアチブに支えられ、活況を呈しています。日本の洗練された医療システムと品質重視の姿勢は、先進的な細胞培養システムにとって重要な市場です。インドの細胞培養市場は、急成長するバイオテクノロジー産業、生物医療研究の増加、ワクチンや生物製剤の生産に後押しされて成長しています。EUは、その強力な研究能力、規制の枠組み、バイオテクノロジーと製薬部門への多額の投資で際立っています。がん研究、再生医療、ワクチン製造などの活発な研究セグメントが、細胞培養製品の需要を牽引しています。加盟国間の共同研究イニシアティブが市場をさらに強化しています。中東・アフリカ地域は、新興地域とはいえ、医療投資の増加やライフサイエンスセグメントでの研究開発活動への緩やかなシフトにより、細胞培養の成長の可能性を示しています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは細胞培養市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を記載しています。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます。フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、細胞培養市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、このセグメントの競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています。

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を記載しています。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発とイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を記載しています。

本レポートは、以下のような主要な質問に対応しています。

1.細胞培養市場の市場規模と予測は？

2.細胞培養市場の予測期間中に投資を検討すべき製品、セグメント、用途、セグメントは何か？

3.細胞培養市場の技術動向と規制枠組みは？

4.細胞培養市場における主要ベンダーの市場シェアは？

5.細胞培養市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 治療用途のモノクローナル抗体の需要増加
    • バイオテクノロジーと医薬品調査活動への投資の増加
    • 世界中で慢性疾患の発生率が上昇
  • 抑制要因
    • 高度な細胞培養技術と無菌状態の維持に伴う高コスト
  • 機会
    • 個人の遺伝子プロファイルに合わせた治療を行う個別化医療における細胞培養の使用を拡大
    • 持続可能な食料生産のための細胞培養を使用した培養肉の需要の高まり
  • 課題
    • 培養物の維持の複雑さと汚染のリスク
• 市場セグメンテーション分析
  • 製品：信頼性、拡大性、高度な機能を備えた細胞培養の機器の優先度が高まっています
  • 最終用途：病院や診断試験室での細胞培養の使用を拡大し、効率性と診断精度を高める
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 細胞培養市場：製品別

• イントロダクション
• 消耗品
• 装置

第7章 細胞培養市場：用途別

• イントロダクション
• バイオ医薬品製造
• 診断
• 医薬品のスクリーニングと開発
• 幹細胞調査
• 組織工学と再生医療

第8章 細胞培養市場：最終用途別

• イントロダクション
• 病院と診断ラボ
• 製薬・バイオテクノロジー企業
• 研究・学術機関

第9章 南北アメリカの細胞培養市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の細胞培養市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの細胞培養市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

第13章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. CELL CULTURE MARKET RESEARCH PROCESS
• FIGURE 2. CELL CULTURE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. CELL CULTURE MARKET DYNAMICS
• FIGURE 7. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. CELL CULTURE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. CELL CULTURE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CELL CULTURE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CELL CULTURE MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL CELL CULTURE MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTOR ACCESSORIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTOR ACCESSORIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL CELL CULTURE MARKET SIZE, BY CLASSICAL MEDIA & SALTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL CELL CULTURE MARKET SIZE, BY CLASSICAL MEDIA & SALTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL CELL CULTURE MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL CELL CULTURE MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL CELL CULTURE MARKET SIZE, BY SPECIALTY MEDIA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL CELL CULTURE MARKET SIZE, BY SPECIALTY MEDIA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL CULTURE MEDIA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL CULTURE MEDIA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL CELL CULTURE MARKET SIZE, BY ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL CELL CULTURE MARKET SIZE, BY ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL CELL CULTURE MARKET SIZE, BY ATTACHMENT & MATRIX FACTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL CELL CULTURE MARKET SIZE, BY ATTACHMENT & MATRIX FACTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL CELL CULTURE MARKET SIZE, BY BALANCED SALT SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL CELL CULTURE MARKET SIZE, BY BALANCED SALT SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL CELL CULTURE MARKET SIZE, BY BUFFERS & CHEMICALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL CELL CULTURE MARKET SIZE, BY BUFFERS & CHEMICALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL CELL CULTURE MARKET SIZE, BY CELL DISSOCIATION REAGENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL CELL CULTURE MARKET SIZE, BY CELL DISSOCIATION REAGENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL CELL CULTURE MARKET SIZE, BY CONTAMINATION DETECTION KITS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL CELL CULTURE MARKET SIZE, BY CONTAMINATION DETECTION KITS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOPROTECTIVE REAGENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOPROTECTIVE REAGENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL CELL CULTURE MARKET SIZE, BY ADULT BOVINE SERA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL CELL CULTURE MARKET SIZE, BY ADULT BOVINE SERA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL CELL CULTURE MARKET SIZE, BY FETAL BOVINE SERA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL CELL CULTURE MARKET SIZE, BY FETAL BOVINE SERA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 59. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
• TABLE 60. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
• TABLE 61. GLOBAL CELL CULTURE MARKET SIZE, BY CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 62. GLOBAL CELL CULTURE MARKET SIZE, BY CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 63. GLOBAL CELL CULTURE MARKET SIZE, BY FLASKS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 64. GLOBAL CELL CULTURE MARKET SIZE, BY FLASKS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 65. GLOBAL CELL CULTURE MARKET SIZE, BY MULTIWELL PLATES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 66. GLOBAL CELL CULTURE MARKET SIZE, BY MULTIWELL PLATES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 67. GLOBAL CELL CULTURE MARKET SIZE, BY PETRI DISHES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 68. GLOBAL CELL CULTURE MARKET SIZE, BY PETRI DISHES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 69. GLOBAL CELL CULTURE MARKET SIZE, BY ROLLER/ROUX BOTTLES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 70. GLOBAL CELL CULTURE MARKET SIZE, BY ROLLER/ROUX BOTTLES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 71. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 72. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 73. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 74. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 75. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 76. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 77. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 78. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 79. GLOBAL CELL CULTURE MARKET SIZE, BY CONVENTIONAL BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 80. GLOBAL CELL CULTURE MARKET SIZE, BY CONVENTIONAL BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 81. GLOBAL CELL CULTURE MARKET SIZE, BY SINGLE-USE BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 82. GLOBAL CELL CULTURE MARKET SIZE, BY SINGLE-USE BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 83. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 84. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 85. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 86. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 87. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOSTORAGE SYSTEM, BY REGION, 2018-2023 (USD MILLION)
• TABLE 88. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOSTORAGE SYSTEM, BY REGION, 2024-2030 (USD MILLION)
• TABLE 89. GLOBAL CELL CULTURE MARKET SIZE, BY REFRIGERATORS & FREEZERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 90. GLOBAL CELL CULTURE MARKET SIZE, BY REFRIGERATORS & FREEZERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 91. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 92. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 93. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 94. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 95. GLOBAL CELL CULTURE MARKET SIZE, BY AUTOCLAVES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 96. GLOBAL CELL CULTURE MARKET SIZE, BY AUTOCLAVES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 97. GLOBAL CELL CULTURE MARKET SIZE, BY BIOSAFETY CABINETS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 98. GLOBAL CELL CULTURE MARKET SIZE, BY BIOSAFETY CABINETS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 99. GLOBAL CELL CULTURE MARKET SIZE, BY CARBON DIOXIDE INCUBATORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 100. GLOBAL CELL CULTURE MARKET SIZE, BY CARBON DIOXIDE INCUBATORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 101. GLOBAL CELL CULTURE MARKET SIZE, BY CELL COUNTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 102. GLOBAL CELL CULTURE MARKET SIZE, BY CELL COUNTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 103. GLOBAL CELL CULTURE MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 104. GLOBAL CELL CULTURE MARKET SIZE, BY CENTRIFUGES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 105. GLOBAL CELL CULTURE MARKET SIZE, BY FILTRATION SYSTEM, BY REGION, 2018-2023 (USD MILLION)
• TABLE 106. GLOBAL CELL CULTURE MARKET SIZE, BY FILTRATION SYSTEM, BY REGION, 2024-2030 (USD MILLION)
• TABLE 107. GLOBAL CELL CULTURE MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 108. GLOBAL CELL CULTURE MARKET SIZE, BY MICROSCOPES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 109. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 110. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 111. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 112. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 113. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 114. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 115. GLOBAL CELL CULTURE MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 116. GLOBAL CELL CULTURE MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 117. GLOBAL CELL CULTURE MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 118. GLOBAL CELL CULTURE MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 119. GLOBAL CELL CULTURE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 120. GLOBAL CELL CULTURE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 121. GLOBAL CELL CULTURE MARKET SIZE, BY DRUG SCREENING & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 122. GLOBAL CELL CULTURE MARKET SIZE, BY DRUG SCREENING & DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 123. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2023 (USD MILLION)
• TABLE 124. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2024-2030 (USD MILLION)
• TABLE 125. GLOBAL CELL CULTURE MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 126. GLOBAL CELL CULTURE MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 127. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 128. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 129. GLOBAL CELL CULTURE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 130. GLOBAL CELL CULTURE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 131. GLOBAL CELL CULTURE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 132. GLOBAL CELL CULTURE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 133. GLOBAL CELL CULTURE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 134. GLOBAL CELL CULTURE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 135. AMERICAS CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 136. AMERICAS CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 137. AMERICAS CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 138. AMERICAS CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 139. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
• TABLE 140. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
• TABLE 141. AMERICAS CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
• TABLE 142. AMERICAS CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
• TABLE 143. AMERICAS CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
• TABLE 144. AMERICAS CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
• TABLE 145. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
• TABLE 146. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
• TABLE 147. AMERICAS CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
• TABLE 148. AMERICAS CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
• TABLE 149. AMERICAS CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 150. AMERICAS CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 151. AMERICAS CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 152. AMERICAS CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 153. AMERICAS CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 154. AMERICAS CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 155. AMERICAS CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 156. AMERICAS CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 157. AMERICAS CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 158. AMERICAS CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 159. AMERICAS CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 160. AMERICAS CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 161. AMERICAS CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 162. AMERICAS CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 163. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 164. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 165. ARGENTINA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 166. ARGENTINA CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 167. ARGENTINA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 168. ARGENTINA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 169. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
• TABLE 170. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
• TABLE 171. ARGENTINA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
• TABLE 172. ARGENTINA CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
• TABLE 173. ARGENTINA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
• TABLE 174. ARGENTINA CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
• TABLE 175. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
• TABLE 176. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
• TABLE 177. ARGENTINA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
• TABLE 178. ARGENTINA CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
• TABLE 179. ARGENTINA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 180. ARGENTINA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 181. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 182. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 183. ARGENTINA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 184. ARGENTINA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 185. ARGENTINA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 186. ARGENTINA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 187. ARGENTINA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 188. ARGENTINA CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 189. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 190. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 191. ARGENTINA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 192. ARGENTINA CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 193. BRAZIL CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 194. BRAZIL CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 195. BRAZIL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 196. BRAZIL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 197. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
• TABLE 198. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
• TABLE 199. BRAZIL CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
• TABLE 200. BRAZIL CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
• TABLE 201. BRAZIL CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
• TABLE 202. BRAZIL CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
• TABLE 203. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
• TABLE 204. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
• TABLE 205. BRAZIL CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
• TABLE 206. BRAZIL CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
• TABLE 207. BRAZIL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 208. BRAZIL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 209. BRAZIL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 210. BRAZIL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 211. BRAZIL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 212. BRAZIL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 213. BRAZIL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 214. BRAZIL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 215. BRAZIL CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 216. BRAZIL CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 217. BRAZIL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 218. BRAZIL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 219. BRAZIL CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 220. BRAZIL CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 221. CANADA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 222. CANADA CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 223. CANADA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 224. CANADA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 225. CANADA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
• TABLE 226. CANADA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
• TABLE 227. CANADA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
• TABLE 228. CANADA CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
• TABLE 229. CANADA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
• TABLE 230. CANADA CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
• TABLE 231. CANADA CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
• TABLE 232. CANADA CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
• TABLE 233. CANADA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
• TABLE 234. CANADA CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
• TABLE 235. CANADA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 236. CANADA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 237. CANADA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 238. CANADA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 239. CANADA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 240. CANADA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 241. CANADA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 242. CANADA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 243. CANADA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 244. CANADA CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 245. CANADA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 246. CANADA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 247. CANADA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 248. CANADA CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 249. MEXICO CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 250. MEXICO CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 251. MEXICO CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 252. MEXICO CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 253. MEXICO CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
• TABLE 254. MEXICO CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
• TABLE 255. MEXICO CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
• TABLE 256. MEXICO CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
• TABLE 257. MEXICO CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
• TABLE 258. MEXICO CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
• TABLE 259. MEXICO CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
• TABLE 260. MEXICO CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
• TABLE 261. MEXICO CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
• TABLE 262. MEXICO CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
• TABLE 263. MEXICO CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 264. MEXICO CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 265. MEXICO CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 266. MEXICO CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 267. MEXICO CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 268. MEXICO CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 269. MEXICO CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 270. MEXICO CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 271. MEXICO CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 272. MEXICO CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 273. MEXICO CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 274. MEXICO CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 275. MEXICO CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 276. MEXICO CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 277. UNITED STATES CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 278. UNITED STATES CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 279. UNITED STATES CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 280. UNITED STATES CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 281. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
• TABLE 282. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
• TABLE 283. UNITED STATES CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
• TABLE 284. UNITED STATES CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
• TABLE 285. UNITED STATES CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
• TABLE 286. UNITED STATES CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
• TABLE 287. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
• TABLE 288. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
• TABLE 289. UNITED STATES CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
• TABLE 290. UNITED STATES CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
• TABLE 291. UNITED STATES CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 292. UNITED STATES CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 293. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 294. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 295. UNITED STATES CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 296. UNITED STATES CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 297. UNITED STATES CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 298. UNITED STATES CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 299. UNITED STATES CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 300. UNITED STATES CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 301. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 302. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 303. UNITED STATES CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 304. UNITED STATES CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 305. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 306. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 307. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 308. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 309. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 310. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 311. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
• TABLE 312. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
• TABLE 313. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
• TABLE 314. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
• TABLE 315. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
• TABLE 316. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
• TABLE 317. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
• TABLE 318. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
• TABLE 319. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
• TABLE 320. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
• TABLE 321. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 322. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 323. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 324. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 325. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 326. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 327. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 328. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 329. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 330. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 331. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 332. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 333. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 334. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 335. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 336. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 337. AUSTRALIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 338. AUSTRALIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 339. AUSTRALIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 340. AUSTRALIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 341. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
• TABLE 342. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
• TABLE 343. AUSTRALIA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
• TABLE 344. AUSTRALIA CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
• TABLE 345. AUSTRALIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
• TABLE 346. AUSTRALIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
• TABLE 347. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
• TABLE 348. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
• TABLE 349. AUSTRALIA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
• TABLE 350. AUSTRALIA CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
• TABLE 351. AUSTRALIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 352. AUSTRALIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 353. AUSTRALIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 354. AUSTRALIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 355. AUSTRALIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 356. AUSTRALIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 357. AUSTRALIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 358. AUSTRALIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 359. AUSTRALIA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 360. AUSTRALIA C

[186 Pages Report] The Cell Culture Market size was estimated at USD 26.29 billion in 2023 and expected to reach USD 30.12 billion in 2024, at a CAGR 14.58% to reach USD 68.20 billion by 2030.

Cell culture is a laboratory method used to grow cells in a controlled environment outside of their natural setting, such as a living organism. This method allows researchers and scientists to study the behavior, biology, and physiology of cells in detail. Cell culture is utilized in various fields, including medical research, pharmaceuticals, biotechnology, and even some aspects of manufacturing. The applications of cell culture technology are vast and varied, encompassing drug development, vaccine production, cancer research, genetic engineering, and the manufacture of biologics, among others. It plays a crucial role in developing new medicines, testing for toxicity, and understanding disease mechanisms. In the pharmaceutical and biotechnology industries, cell culture is pivotal in producing biopharmaceuticals and antibodies. Moreover, its role in regenerative medicine and tissue engineering underlines its significance in developing therapeutic strategies for chronic diseases and conditions. Several factors contribute positively to the growth of the cell culture market, including innovations in cell culture technologies, such as 3D cell culture and automated cell culture systems, growing demand for monoclonal antibodies for therapeutic applications, higher investment in biotechnology and pharmaceutical research activities, and rising incidence of chronic diseases worldwide. However, the cell culture market faces certain limitations, such as the high costs associated with advanced cell culture technologies, ethical issues, the complexity of maintaining cultures, and the risk of contamination. On the other hand, advancements in 3D cell culture technology, the use of cell culture in personalized medicine for tailoring treatments to individual genetic profiles, research into cell culture applications in regenerative medicine, and the burgeoning field of cultured meat, using cell culture for sustainable food production opens new avenues for the development of cell culture market.

Product: Increasing preference for equipments in cell culture for reliability, scalability, and advanced features

Consumables are products that are regularly used up and need replacement. They play a critical role in ensuring the quality and integrity of cell culture work. Bioreactor accessories are components used with bioreactors, devices that support a biologically active environment, to improve their efficiency and output. Media is the nutrient-rich solution that cells grow in, and It can be divided into classical media & salts and serum-free media. Reagents are substances or compounds added to the cell culture to bring about a desired effect, such as antibiotics/antimycotics used to prevent bacterial/fungal contamination; attachment & matrix factors to help cells attach to the culture vessel; and balanced salt solutions to maintain the osmotic balance and pH. Cell factory systems/cell stacks, flasks, and multiwell plates are containers where cells are grown. They come in various sizes and shapes, tailored to different types of cell culture needs. Conventional bioreactors and single-use bioreactor devices are essential for growing cells in large quantities for research or production purposes. Single-use bioreactors are particularly noted for their convenience and reduced contamination risk. Cryostorage systems, refrigerators & freezers are vital for preserving cells and biological materials at appropriate temperatures, ensuring they remain viable over time. Autoclaves, biosafety cabinets, and carbon dioxide incubators are essential to maintain a sterile environment, ensuring the safety and integrity of cell cultures. Consumables are a continuous expense and can significantly impact the overall cost of cell culture operations in the long term. In contrast, equipment represents a higher initial investment but offers a longer service life, potentially reducing costs over time. Selection of consumables often focuses on quality, batch consistency, and ethical considerations, whereas equipment preferences lean towards reliability, scalability, and advanced features that enhance culture conditions and monitoring.

End-Use: Expanding usage of cell culture in hospitals and diagnostic laboratories for efficiency and diagnostic accuracy

In hospitals and diagnostic laboratories, cell culture is primarily employed for diagnostic purposes, including cancer diagnosis, virology studies, and drug screening. The emphasis is on accuracy, reliability, and speed, with a growing interest in automated cell culture systems to streamline workflow and reduce human error. Pharmaceutical & biotechnology companies prioritize scalability, consistency, and regulatory compliance, given the cell culture applications in drug development, biologics production, and vaccine manufacturing. The focus is on high-yield, cost-effective culture systems that can expedite the time-to-market for new therapeutics. Research and academic institutes focus on flexibility, variety, and specificity in cell culture products to support a broad range of research areas, including stem cell research, cancer research, and regenerative medicine. The demand here is for specialized media formulations, advanced culture systems such as 3D cultures, and support for cutting-edge research endeavors. Upon comparing the three segments, it becomes evident that each has unique requirements shaped by their end goals. Hospitals and diagnostic laboratories prioritize efficiency and diagnostic accuracy, pharmaceutical and biotechnology companies focus on scalability and compliance for therapeutic production, and research and academic institutes demand versatility for a wide swath of research applications.

Regional Insights

The United States, being a hub for biotechnological research and development, stands out as a significant market for cell culture products. The demand here is driven by a robust research infrastructure, substantial investments in life sciences, and the existence of major pharmaceutical and biotechnology companies. The focus on personalized medicine and regenerative therapies further boosts the market. The South American cell culture market is in a growth phase, fueled by increasing investment in research and development by both public and private sectors. The Asia Pacific region is experiencing rapid growth in cell culture demand due to its expanding biopharmaceutical sector, increasing investments in life sciences, and government support for biotechnology startups. China's market is booming, supported by government initiatives aimed at advancing regenerative medicine, biologics production, and stem cell research. Japan's sophisticated healthcare system and strong emphasis on quality are significant markets for advanced cell culture systems. India's cell culture market is growing, fueled by its burgeoning biotech industry, increased biomedical research, and the production of vaccines and biologics. The EU stands out for its strong research capabilities, regulatory frameworks, and substantial investments in the biotechnology and pharmaceutical sectors. The demand for cell culture products is driven by active research areas, including cancer research, regenerative medicine, and vaccine production. Collaborative research initiatives across member states further enhance the market. The Middle East and Africa region, although emerging, shows potential for growth in cell culture due to increasing healthcare investment and a gradual shift towards research and developmental activities in the life sciences sector.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Culture Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Culture Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Culture Market, highlighting leading vendors and their innovative profiles. These include Adolf Kuhner AG, Advancion Corporation, Agilent Technologies, Inc., Becton, Dickinson, and Company, Bio-Techne Corporation, BioSpherix Ltd., Caisson Labs Inc., CellGenix GmbH, Corning Incorporated, Danaher Corporation, Emulate, Inc., Eppendorf AG, Fujifilm Holdings Corporation, Getinge AB, Hi-Media Laboratories, InSphero AG, Invivogen, Lonza Group, Merck & Co., Inc., Miltenyi Biotec, PAN-Biotech GmbH, PromoCell GmbH, Sartorius AG, Solida Biotech GmBH, STEMCELL Technologies Canada Inc., Synthecon, Incorporated, Thermo Fisher Scientific Inc., and VWR International, LLC by Avantor, Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Culture Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Consumables
    • Bioreactor Accessories
    • Sera, Media, and Reagents
      • Media Classical Media & Salts

Serum-Free Media

Specialty Media

Stem Cell Culture Media

• Reagents Antibiotics/Antimycotics

Attachment & Matrix Factors

Balanced Salt Solutions

Buffers & Chemicals

Cell Dissociation Reagents

Contamination Detection Kits

Cryoprotective Reagents

• Sera Adult Bovine Sera

Fetal Bovine Sera

• Vessels
  • Cell Factory Systems/Cell Stacks
  • Flasks
  • Multiwell Plates
  • Petri Dishes
  • Roller/Roux Bottles
• Equipment
  • Bioreactors
    • Conventional Bioreactors
    • Single-Use Bioreactors

• Storage Equipment
  • Cryostorage System
  • Refrigerators & Freezers

• Supporting Equipment
  • Autoclaves
  • Biosafety Cabinets
  • Carbon Dioxide Incubators
  • Cell Counters
  • Centrifuges
  • Filtration System
  • Microscopes
• Application
  • Biopharmaceutical Production
    • Monoclonal Antibody Production
    • Vaccine Production

• Diagnostics
• Drug Screening & Development
• Stem Cell Research
• Tissue Engineering & Regenerative Medicine

• End-Use
  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell Culture Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Culture Market?

3. What are the technology trends and regulatory frameworks in the Cell Culture Market?

4. What is the market share of the leading vendors in the Cell Culture Market?

5. Which modes and strategic moves are suitable for entering the Cell Culture Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing demand for monoclonal antibodies for therapeutic applications
    • 5.1.1.2. Increased investment in biotechnology and pharmaceutical research activities
    • 5.1.1.3. Rising incidence of chronic diseases worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with advanced cell culture technologies and the maintenance of sterile conditions
  • 5.1.3. Opportunities
    • 5.1.3.1. Expanding the use of cell culture in personalized medicine for tailored treatments to individual genetic profiles
    • 5.1.3.2. Burgeoning demand for cultured meat, using cell culture for sustainable food production
  • 5.1.4. Challenges
    • 5.1.4.1. The complexity of maintaining cultures and the risk of contamination
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing preference for equipments in cell culture for reliability, scalability, and advanced features
  • 5.2.2. End-Use: Expanding usage of cell culture in hospitals and diagnostic laboratories for efficiency and diagnostic accuracy
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Cell Culture Market, by Product

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Equipment

7. Cell Culture Market, by Application

• 7.1. Introduction
• 7.2. Biopharmaceutical Production
• 7.3. Diagnostics
• 7.4. Drug Screening & Development
• 7.5. Stem Cell Research
• 7.6. Tissue Engineering & Regenerative Medicine

8. Cell Culture Market, by End-Use

• 8.1. Introduction
• 8.2. Hospitals & Diagnostic Laboratories
• 8.3. Pharmaceutical & Biotechnology Companies
• 8.4. Research & Academic Institutes

9. Americas Cell Culture Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cell Culture Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cell Culture Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Novartis Embarks on a USD 500 Million Expansion Project in Austrian Biopharmaceutical Manufacturing
  • 12.3.2. Molecular Devices Unveils the CellXpress AI Automated Cell Culture System
  • 12.3.3. Strategic Alliance Elevates Stem Cell Research Accessibility and Efficiency
• 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio